Trump’s Reciprocal Tariffs: Indian Pharma Faces Uncertain Future
April 2 is expected to bring a seismic shift for Indian pharmaceutical companies as Donald Trump’s proposed reciprocal tariffs take effect. While the world waits for an official announcement on the specifics, Indian drug manufacturers are bracing for a hit that could reshape their access to the US market. Pharma Industry in the Crosshairs A large chunk of India’s pharmaceutical exports heads to the United States, making the sector vulnerable…